How I approach: the transplant recipient with fever and pulmonary infiltrates

Madan Kumar1, Benjamin R Hanisch2

  • 1Section of Pediatric Infectious Diseases, University of Chicago, Chicago, IL, United States.

PubMed

Insights

Diagnosing pulmonary infiltrates after stem cell or organ transplants in children is challenging. This paper presents a clinical approach for these complex cases, focusing on infectious and non-infectious causes.

Area of Science:

  • Pediatric Medicine
  • Pulmonology
  • Transplant Medicine

Background:

  • Pulmonary infiltrates are common complications in pediatric hematopoietic stem cell transplant (HSCT) and solid organ transplant (SOT) recipients.
  • Identifying the specific infectious (viral, bacterial, fungal) or non-infectious causes is often difficult.
  • Pediatric patients present unique diagnostic challenges due to limitations in invasive procedures like bronchoscopy or lung biopsy.

Purpose of the Study:

  • To summarize an initial clinical approach for diagnosing and managing pulmonary infiltrates in pediatric transplant recipients.
  • To discuss the evidence base guiding clinical practices for these complex cases.
  • To highlight generalizable diagnostic and management strategies, considering clinical course and risk factors.

Main Methods:

  • Review of clinical approach and relevant literature.
  • Presentation of a case study involving a pediatric HSCT recipient with characteristic pulmonary infiltrates.
  • Discussion of diagnostic considerations and management strategies.

Main Results:

  • The paper outlines a practical framework for evaluating pulmonary infiltrates in pediatric transplant patients.
  • It emphasizes the challenges in differentiating infectious from non-infectious etiologies.
  • Key risk factors and clinical course considerations are highlighted.

Conclusions:

  • A structured approach is crucial for managing pulmonary infiltrates in pediatric transplant recipients.
  • Tailoring diagnostic and therapeutic strategies based on individual patient factors is essential.
  • Further research is needed to establish well-defined, generalizable guidelines.

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
242
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
366
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
142
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324